I 
1.72
-1.15%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Integral Diagnostics
Its shares trade on ASX under the ticker IDX.AX. It has been listed since 21 October 2015. In the fiscal year to 30 June 2026, it reported revenue of A$788.6m and net income of A$21.9m. At that date it held total assets of A$1.46bn and shareholders' equity of A$676.0m.
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services across Australia and New Zealand. The firm provides diagnostic services to patients and their referrers at approximately 71 radiology clinics, including 29 comprehensive sites. The company offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. The company also operates in New Zealand through the Astra Radiology, SRG Radiology and Trinity MRI brands. The firm offers its services through its subsidiaries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 21 Oct 2015
- Employees
- 1,868
- Website
- integraldiagnostics.com.au ↗
Leadership
Pay as last reported
- Mr. Toby HallIndependent Non-Executive Director and Chair ElectA$250,458
- Dr. Ian KadishChief Executive Officer, Managing Director, Executive Director, since 2017A$1.2m
- Mr. Craig WhiteChief Financial OfficerA$917,785
- Dr. Manish MittalRadiologist Executive Director, since 2025A$347,945
- Mr. John MerityCompany Secretary
- Mr. Andrew FayNon-Executive Independent DirectorA$137,500
- Ms. Laura McbainNon-Executive Independent DirectorA$63,470
- Ms. Raelene MurphyNon-Executive Independent DirectorA$150,000
- Ms. Ingrid PlayerNon-Executive Independent DirectorA$150,000
- Dr. Kevin ShawNon-Executive Independent DirectorA$63,470
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 75
- Environment
- 52
- Social
- 99
- Governance
- 74
- Direct emissions (scope 1)
- 750.3 t
- Energy emissions (scope 2)
- 8,753.5 t
- Women in the workforce
- 75.47%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Integral Diagnostics Ltd has several notable strengths that contribute to its success in the healthcare industry. Firstly, the company has an extensive network of medical imaging centers, allowing it to reach a wide customer base. This allows for increased market penetration and revenue generation. Additionally, Integral Diagnostics has a strong reputation for providing high-quality diagnostic services, which enhances its competitive advantage. The company also boasts a team of skilled and experienced medical professionals who provide accurate and reliable diagnoses, further solidifying its position in the market.
- Despite its strengths, Integral Diagnostics Ltd faces several weaknesses that it needs to address. One weakness is the company's dependency on Medicare reimbursement rates for a significant portion of its revenue. This exposes the business to potential changes in government policies and regulations, which could negatively impact its financial performance. Another weakness is the limited geographical presence of Integral Diagnostics, primarily operating in Australia. This reduces its ability to capitalize on international market opportunities and diversify its revenue streams.
- Integral Diagnostics Ltd has identified several opportunities for future growth. With the increasing demand for medical imaging services globally, the company can expand its operations internationally to tap into new markets. By leveraging advancements in technology, such as artificial intelligence and telemedicine, Integral Diagnostics can enhance its service offerings and improve efficiency. Furthermore, partnerships and collaborations with healthcare providers can lead to mutually beneficial arrangements and provide access to a larger patient population.
- The healthcare industry poses various threats to Integral Diagnostics Ltd. One major threat is the potential disruption caused by new competitors entering the market with innovative diagnostic technologies or business models. This could challenge the company's market share and competitive position. Additionally, changes in healthcare policies and regulations, both domestically and internationally, could affect reimbursement rates and operational requirements, disrupting Integral Diagnostics' financial performance and operations. Lastly, economic downturns and declines in healthcare spending can impact the overall demand for medical imaging services, creating a threat to the company's revenue generation.
Weaknesses
- Despite its strengths, Integral Diagnostics Ltd faces several weaknesses that it needs to address. One weakness is the company's dependency on Medicare reimbursement rates for a significant portion of its revenue. This exposes the business to potential changes in government policies and regulations, which could negatively impact its financial performance. Another weakness is the limited geographical presence of Integral Diagnostics, primarily operating in Australia. This reduces its ability to capitalize on international market opportunities and diversify its revenue streams.
- Integral Diagnostics Ltd has identified several opportunities for future growth. With the increasing demand for medical imaging services globally, the company can expand its operations internationally to tap into new markets. By leveraging advancements in technology, such as artificial intelligence and telemedicine, Integral Diagnostics can enhance its service offerings and improve efficiency. Furthermore, partnerships and collaborations with healthcare providers can lead to mutually beneficial arrangements and provide access to a larger patient population.
- The healthcare industry poses various threats to Integral Diagnostics Ltd. One major threat is the potential disruption caused by new competitors entering the market with innovative diagnostic technologies or business models. This could challenge the company's market share and competitive position. Additionally, changes in healthcare policies and regulations, both domestically and internationally, could affect reimbursement rates and operational requirements, disrupting Integral Diagnostics' financial performance and operations. Lastly, economic downturns and declines in healthcare spending can impact the overall demand for medical imaging services, creating a threat to the company's revenue generation.
Opportunities
- Integral Diagnostics Ltd has identified several opportunities for future growth. With the increasing demand for medical imaging services globally, the company can expand its operations internationally to tap into new markets. By leveraging advancements in technology, such as artificial intelligence and telemedicine, Integral Diagnostics can enhance its service offerings and improve efficiency. Furthermore, partnerships and collaborations with healthcare providers can lead to mutually beneficial arrangements and provide access to a larger patient population.
- The healthcare industry poses various threats to Integral Diagnostics Ltd. One major threat is the potential disruption caused by new competitors entering the market with innovative diagnostic technologies or business models. This could challenge the company's market share and competitive position. Additionally, changes in healthcare policies and regulations, both domestically and internationally, could affect reimbursement rates and operational requirements, disrupting Integral Diagnostics' financial performance and operations. Lastly, economic downturns and declines in healthcare spending can impact the overall demand for medical imaging services, creating a threat to the company's revenue generation.
Threats
- The healthcare industry poses various threats to Integral Diagnostics Ltd. One major threat is the potential disruption caused by new competitors entering the market with innovative diagnostic technologies or business models. This could challenge the company's market share and competitive position. Additionally, changes in healthcare policies and regulations, both domestically and internationally, could affect reimbursement rates and operational requirements, disrupting Integral Diagnostics' financial performance and operations. Lastly, economic downturns and declines in healthcare spending can impact the overall demand for medical imaging services, creating a threat to the company's revenue generation.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.